BIOLOGY OF LENTIVIRUS SURFACE CARBOHYDRATES
慢病毒表面碳水化合物的生物学
基本信息
- 批准号:3139369
- 负责人:
- 金额:$ 15.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1987
- 资助国家:美国
- 起止时间:1987-09-15 至 1991-08-31
- 项目状态:已结题
- 来源:
- 关键词:O glycosidase Retroviridae antibody neutralization test antibody specificity antiserum antiviral antibody carbohydrate structure carbohydrates cell fusion chemical binding enzyme inhibitors exoenzyme glycopeptides glycosyltransferase human immunodeficiency virus 1 immune complex macrophage oligosaccharides peptidases phagocytosis radiotracer receptor mediated endocytosis sialate tissue /cell culture virus antigen virus infection mechanism virus morphology virus receptors virus replication
项目摘要
HIV and the animal lentiviruses are poor inducers of neutralizing
antibodies either during infection or in immunized experimental
animals. Further, the effectiveness of neutralizing antibodies in
protecting against HIV Infection is difficult to evaluate because
of lack of data on differences between the affinity of antibodies
for the virus and virus for the host cell. Studies on neutralization
of the animal lentiviruses show that affinity between antibodies
and virus is very low. Morevoer, viruses which are the poorest
inducers of, and reactors with, neutralizing antobides are covered
with a dense layer of carbohydrates. Our hypothesis is that viral
surface carbohydrates are crucial for inducing and reacting with
neutralizing antibodies and for binding to cells. Preliminary data
already show that neuraminidase has major biological effects on
the viruses. Using various substrates of virus, virus-infected cells
and deglycosylated virus-infected cells to absorb immune sera; we
will determine whether virus surface carbohydrates are the major
epitopes in virus neutralization. We will also determine whether
the viral carbohydrates are essential for binding of the virus to
cells and later penetration of the cells. Finally, we will perform a
detailed analysis of the structure of the viral carbohydrates with
respect to O- and N-linked glycosylation on two prototype viruses
that vary widely in biological properties.
HIV和动物慢病毒是较差的中和诱导剂
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
OPENDRA NARAYAN其他文献
OPENDRA NARAYAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('OPENDRA NARAYAN', 18)}}的其他基金
COBRE KS: NOVEL APPROACHES TO CONTROL MICROBIAL PATHOGENS: ADMINISTRATIVE CORE
COBRE KS:控制微生物病原体的新方法:管理核心
- 批准号:
7609891 - 财政年份:2007
- 资助金额:
$ 15.69万 - 项目类别:
SAFETY AND EFFICACY OF SHIV VACCINE IN MACAQUES
SHIV 疫苗在猕猴中的安全性和有效性
- 批准号:
7349277 - 财政年份:2006
- 资助金额:
$ 15.69万 - 项目类别:
COBRE KS: NOVEL APPROACHES TO CONTROL MICROBIAL PATHOGENS: ADMINISTRATIVE CORE
COBRE KS:控制微生物病原体的新方法:管理核心
- 批准号:
7381279 - 财政年份:2006
- 资助金额:
$ 15.69万 - 项目类别:
COBRE KS: NOVEL APPROACHES TO CONTROL MICROBIAL PATHOGENS: ADMINISTRATIVE CORE
COBRE KS:控制微生物病原体的新方法:管理核心
- 批准号:
7170515 - 财政年份:2005
- 资助金额:
$ 15.69万 - 项目类别:
A New DNA Vaccine Against HIV Disease in Macaques
一种针对猕猴 HIV 疾病的新型 DNA 疫苗
- 批准号:
7071085 - 财政年份:2004
- 资助金额:
$ 15.69万 - 项目类别:
A New DNA Vaccine Against HIV Disease in Macaques
一种针对猕猴 HIV 疾病的新型 DNA 疫苗
- 批准号:
6841792 - 财政年份:2004
- 资助金额:
$ 15.69万 - 项目类别:
SHIV MACAQUE MODEL OF ORAL IMMUNIZATION AGAINST HIV
艾滋病病毒口服免疫的 SHIV 猕猴模型
- 批准号:
6971023 - 财政年份:2004
- 资助金额:
$ 15.69万 - 项目类别:
A New DNA Vaccine Against HIV Disease in Macaques
一种针对猕猴 HIV 疾病的新型 DNA 疫苗
- 批准号:
7083279 - 财政年份:2004
- 资助金额:
$ 15.69万 - 项目类别:
SAFETY AND EFFICACY OF SHIV VACCINE IN MACAQUES
SHIV 疫苗在猕猴中的安全性和有效性
- 批准号:
6971067 - 财政年份:2004
- 资助金额:
$ 15.69万 - 项目类别:
SHIV MACAQUE MODEL OF ORAL IMMUNIZATION AGAINST SEXUALLY TRANSMITTED HIV
针对性传播艾滋病毒的口服免疫的 SHIV 猕猴模型
- 批准号:
6939968 - 财政年份:2003
- 资助金额:
$ 15.69万 - 项目类别: